Impact of donor-derived U-NK cells on post-transplant outcomes in the total and propensity score–matched (PSM) cohorts. (IMAGE)

Science China Press

Impact of donor-derived U-NK cells on post-transplant outcomes in the total and propensity score–matched (PSM) cohorts.

Caption

(a–f) Neutrophil and platelet engraftment, cumulative incidence of relapse (CIR), treatment-related mortality (TRM), overall survival (OS), and 2.5-year landmark disease-free survival (DFS) in the total cohort, comparing U-NK+ (n = 693) and U-NK− (n = 283) donor groups. (g–l) Corresponding outcomes in the PSM cohort, comparing U-NK+  (n = 503) and U-NK− (n = 275) donor groups; OS and DFS were assessed using 1-year and 2.5-year landmark analyses, respectively.

Credit

©Science Bulletin

Usage Restrictions

use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.